Skip to content
GCC AI Research

Search

Results for "metabolic pathways"

A secret language of cells? New cell computations uncovered

KAUST ·

KAUST and EPFL Blue Brain Project researchers propose a new theory about a 'secret language' used by cells for internal communication regarding the external world. Using a computational model, they suggest that metabolic pathways can code details about neuromodulators that stimulate energy consumption. The model focuses on astrocytes and their cooperation with neurons in fueling the brain. Why it matters: This suggests a new avenue for understanding information processing in the brain and how cells contribute to the energy efficiency of brains compared to computers.

Turning spoiled food waste into commercial products

KAUST ·

KAUST researchers have developed a technology to convert spoiled dairy and fruit beverages into valuable short-chain and medium-chain carboxylic acids (SCCAs and MCCAs). These acids can be used for animal feed, aviation fuel, and pharmaceuticals, with SCCAs valued at $300 per ton and MCCAs having 10x higher value. A pilot study is underway at KAUST, utilizing over 500 liters of waste per week from regional companies. Why it matters: This innovation supports Saudi Arabia's goal to eliminate 90% of landfill waste by 2040 and promotes a circular economy by transforming food waste into high-value products.

Algae — a metabolic treasure trove

KAUST ·

KAUST researchers are exploring the potential of algae for various high-value applications, including animal feed, crop fertilizers, and waste remediation. Claudio Grunewald directs a project focused on producing high-protein algae for agriculture. Kyle Lauersen brings expertise in algal synthetic biology and metabolic engineering. Why it matters: Investment in algae research and biotechnology could yield significant returns for Saudi Arabia, contributing to sustainable solutions and economic diversification.

Disease in a dish

KAUST ·

KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.